Literature DB >> 8233683

Mucopolysaccharidosis: thickening of dura mater at the craniocervical junction and other CT/MRI findings.

A Taccone1, P Tortori Donati, A Marzoli, A Dell'Acqua, R Gatti, D Leone.   

Abstract

Cranial CT and/or MRI imaging of 8 patients with mucopolysaccharidosis (MPS) was retrospectively evaluated. Two patients had MPS IH, 1 had MPS IS, 1 had MPS IVA and 4 had MPS IV. CT and MRI showed thickening of dura mater at the cranio-cervical junction, causing narrowing of the subarachnoid space, in all the patients examined. Spinal cord compression was detected in 4 patients. Other findings were: white matter alterations, mild to severe hydrocephalus, skull dysplasia and odontoid dysplasia. White matter alterations were evident as large areas and as multiple dispersed spots of prolonged T1 and T2 value. Reduced gray/white matter contrast was demonstrated on T2-weighted MRI images. It is important to examine the cranio-cervical junction carefully for thickening of dura mater in all patients with mucopolysaccharidosis examined by CT or MRI, because of the generally progressive clinical course of MPS. In patients with symptomatic cord compression, surgical intervention should be considered.

Entities:  

Mesh:

Year:  1993        PMID: 8233683     DOI: 10.1007/bf02011954

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  17 in total

1.  MR imaging of cavitary lesions in the brain with Hurler/Scheie.

Authors:  R A Rauch; L A Friloux; I T Lott
Journal:  AJNR Am J Neuroradiol       Date:  1989 Sep-Oct       Impact factor: 3.825

2.  Spinal cord compression in Morquio-Brailsford's disease.

Authors:  M E Blaw; L O Langer
Journal:  J Pediatr       Date:  1969-04       Impact factor: 4.406

3.  Spastic quadriparesis due to C1-C2 subluxation in Hurler syndrome.

Authors:  C B Brill; J S Rose; L Godmilow; S Sklower; J Willner; K Hirschhorn
Journal:  J Pediatr       Date:  1978-03       Impact factor: 4.406

4.  The value of computed tomography in patients with mucopolysaccharidosis.

Authors:  J Nelson; F S Grebbell
Journal:  Neuroradiology       Date:  1987       Impact factor: 2.804

5.  Computed tomography studies on patients with mucopolysaccharidoses.

Authors:  R W Watts; E Spellacy; B E Kendall; G du Boulay; D A Gibbs
Journal:  Neuroradiology       Date:  1981-02       Impact factor: 2.804

6.  Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux-Lamy syndrome: report of a case.

Authors:  N Tamaki; N Kojima; M Tanimoto; T Suyama; S Matsumoto
Journal:  Neurosurgery       Date:  1987-09       Impact factor: 4.654

7.  Deficiency of arylsulfatase B in 2 brothers aged 40 and 38 years (Maroteaux-Lamy syndrome, type B).

Authors:  H Pilz; K von Figura; H H Goebel
Journal:  Ann Neurol       Date:  1979-10       Impact factor: 10.422

8.  [Mucopolysaccharidosis IV-A (Maroteaux-Lamy disease, severe form): incipient compressive myelopathy, cerebrospinal fluid fistula and tracheal stenosis in an adult patient].

Authors:  S Rampini; W Grauer; H G Imhof; R Gitzelmann
Journal:  Helv Paediatr Acta       Date:  1986-03

9.  MR imaging of the brain in patients with mucopolysaccharidosis.

Authors:  R Murata; S Nakajima; A Tanaka; N Miyagi; O Matsuoka; S Kogame; Y Inoue
Journal:  AJNR Am J Neuroradiol       Date:  1989 Nov-Dec       Impact factor: 3.825

10.  Mucopolysaccharidosis type I, II, IIIA and V. Pathological and biochemical abnormalities in the neural and mesenchymal elements of the brain.

Authors:  A S Dekaban; G Constantopoulos
Journal:  Acta Neuropathol       Date:  1977-07-15       Impact factor: 17.088

View more
  10 in total

1.  Intrathecal gene therapy corrects CNS pathology in a feline model of mucopolysaccharidosis I.

Authors:  Christian Hinderer; Peter Bell; Brittney L Gurda; Qiang Wang; Jean-Pierre Louboutin; Yanqing Zhu; Jessica Bagel; Patricia O'Donnell; Tracey Sikora; Therese Ruane; Ping Wang; Mark E Haskins; James M Wilson
Journal:  Mol Ther       Date:  2014-07-16       Impact factor: 11.454

2.  Cerebral magnetic resonance findings during enzyme replacement therapy in mucopolysaccharidosis.

Authors:  Yoshiko Matsubara; Osamu Miyazaki; Motomichi Kosuga; Torayuki Okuyama; Shunsuke Nosaka
Journal:  Pediatr Radiol       Date:  2017-07-21

Review 3.  Brain and spinal MR imaging findings in mucopolysaccharidoses: a review.

Authors:  D I Zafeiriou; S P Batzios
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-12       Impact factor: 3.825

4.  Biodistribution and pharmacodynamics of recombinant human alpha-L-iduronidase (rhIDU) in mucopolysaccharidosis type I-affected cats following multiple intrathecal administrations.

Authors:  Charles H Vite; Ping Wang; Reema T Patel; Raquel M Walton; Steven U Walkley; Rani S Sellers; N Matthew Ellinwood; Alphonsus S Cheng; Joleen T White; Charles A O'Neill; Mark Haskins
Journal:  Mol Genet Metab       Date:  2011-03-21       Impact factor: 4.797

5.  Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates.

Authors:  Christian Hinderer; Peter Bell; Jean-Pierre Louboutin; Yanqing Zhu; Hongwei Yu; Gloria Lin; Ruth Choa; Brittney L Gurda; Jessica Bagel; Patricia O'Donnell; Tracey Sikora; Therese Ruane; Ping Wang; Alice F Tarantal; Margret L Casal; Mark E Haskins; James M Wilson
Journal:  Mol Ther       Date:  2015-05-29       Impact factor: 11.454

6.  Brain and spine MRI features of Hunter disease: frequency, natural evolution and response to therapy.

Authors:  Renzo Manara; Elena Priante; Marco Grimaldi; Lucia Santoro; Luca Astarita; Rita Barone; Daniela Concolino; Maja Di Rocco; Maria Alice Donati; Simona Fecarotta; Anna Ficcadenti; Agata Fiumara; Francesca Furlan; Irene Giovannini; Franco Lilliu; Rodica Mardari; Gabriele Polonara; Elena Procopio; Angelica Rampazzo; Andrea Rossi; Graziolina Sanna; Rossella Parini; Maurizio Scarpa
Journal:  J Inherit Metab Dis       Date:  2011-04-05       Impact factor: 4.982

Review 7.  Spinal involvement in mucopolysaccharidoses: a review.

Authors:  Antonio Leone; Donato Rigante; Daniele Zaccaria Amato; Roberto Casale; Luigi Pedone; Nicola Magarelli; Cesare Colosimo
Journal:  Childs Nerv Syst       Date:  2014-10-31       Impact factor: 1.475

8.  Neonatal tolerance induction enables accurate evaluation of gene therapy for MPS I in a canine model.

Authors:  Christian Hinderer; Peter Bell; Jean-Pierre Louboutin; Nathan Katz; Yanqing Zhu; Gloria Lin; Ruth Choa; Jessica Bagel; Patricia O'Donnell; Caitlin A Fitzgerald; Therese Langan; Ping Wang; Margret L Casal; Mark E Haskins; James M Wilson
Journal:  Mol Genet Metab       Date:  2016-06-08       Impact factor: 4.797

9.  Musculoskeletal manifestations in mucopolysaccharidosis type I (Hurler syndrome) following hematopoietic stem cell transplantation.

Authors:  Mona Schmidt; Sandra Breyer; Ulrike Löbel; Sinef Yarar; Ralf Stücker; Kurt Ullrich; Ingo Müller; Nicole Muschol
Journal:  Orphanet J Rare Dis       Date:  2016-07-08       Impact factor: 4.123

10.  Presentation and Treatments for Mucopolysaccharidosis Type II (MPS II; Hunter Syndrome).

Authors:  Molly Stapleton; Francyne Kubaski; Robert W Mason; Hiromasa Yabe; Yasuyuki Suzuki; Kenji E Orii; Tadao Orii; Shunji Tomatsu
Journal:  Expert Opin Orphan Drugs       Date:  2017-03-08       Impact factor: 0.694

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.